Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5798
-0.0292 (-4.79%)
At close: Jan 30, 2026
Vaxart Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 148.2 | 28.7 | 7.38 | 0.11 | 0.89 | 4.05 | |
Revenue Growth (YoY) | 784.27% | 288.94% | 6796.26% | -88.00% | -77.95% | -58.97% |
Cost of Revenue | 179.08 | 74.21 | 68.14 | 81.05 | 48.75 | 19.86 |
Gross Profit | -30.88 | -45.51 | -60.76 | -80.95 | -47.86 | -15.82 |
Selling, General & Admin | 17.97 | 20.78 | 22.58 | 29.39 | 21.89 | 15.2 |
Operating Expenses | 17.97 | 20.78 | 22.58 | 29.39 | 21.89 | 15.2 |
Operating Income | -48.84 | -66.29 | -83.35 | -110.33 | -69.75 | -31.02 |
Interest Expense | -3.2 | -2.97 | -1.45 | -1.31 | -1.48 | -1.87 |
Interest & Investment Income | 1.65 | 2.54 | 2.65 | 1.25 | 0.08 | 0.08 |
Currency Exchange Gain (Loss) | - | - | - | - | -0 | -0.01 |
Other Non Operating Income (Expenses) | -0 | 0.03 | -0.06 | -0.01 | - | - |
EBT Excluding Unusual Items | -50.4 | -66.69 | -82.2 | -110.4 | -71.15 | -32.83 |
Merger & Restructuring Charges | - | - | - | - | - | 0.85 |
Asset Writedown | - | - | - | -4.25 | -3.01 | - |
Other Unusual Items | - | - | - | 6.96 | 3.79 | - |
Pretax Income | -50.4 | -66.69 | -82.2 | -107.69 | -70.36 | -31.98 |
Income Tax Expense | 0.31 | 0.26 | 0.26 | 0.07 | 0.11 | 0.24 |
Net Income | -50.7 | -66.95 | -82.47 | -107.76 | -70.47 | -32.22 |
Net Income to Common | -50.7 | -66.95 | -82.47 | -107.76 | -70.47 | -32.22 |
Shares Outstanding (Basic) | 228 | 202 | 145 | 128 | 121 | 88 |
Shares Outstanding (Diluted) | 228 | 202 | 145 | 128 | 121 | 88 |
Shares Change (YoY) | 26.28% | 39.58% | 13.42% | 5.13% | 37.55% | 309.35% |
EPS (Basic) | -0.22 | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
EPS (Diluted) | -0.22 | -0.33 | -0.57 | -0.84 | -0.58 | -0.36 |
Free Cash Flow | -30.48 | -45.32 | -72.32 | -104.38 | -64.99 | -24.97 |
Free Cash Flow Per Share | -0.13 | -0.22 | -0.50 | -0.82 | -0.54 | -0.28 |
Gross Margin | -20.83% | -158.58% | - | - | - | - |
Operating Margin | -32.95% | -230.99% | -1129.52% | -103114.95% | -7819.17% | -766.66% |
Profit Margin | -34.21% | -233.27% | -1117.56% | -100708.41% | -7900.22% | -796.34% |
Free Cash Flow Margin | -20.57% | -157.90% | -980.13% | -97551.40% | -7285.76% | -617.23% |
EBITDA | -40.08 | -57.44 | -74.72 | -104.53 | -65.54 | -28.31 |
EBITDA Margin | -27.04% | -200.15% | - | - | - | - |
D&A For EBITDA | 8.76 | 8.85 | 8.62 | 5.81 | 4.21 | 2.71 |
EBIT | -48.84 | -66.29 | -83.35 | -110.33 | -69.75 | -31.02 |
EBIT Margin | -32.95% | -230.99% | - | - | - | - |
Revenue as Reported | 148.2 | 28.7 | 7.38 | 0.11 | 0.89 | 4.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.